Compounds > monocrotaline

monocrotaline and Coronary Disease

monocrotaline has been researched along with Coronary Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
BLAUSTEIN, A; BLAUSTEIN, RL; ROSENBLAT, M1
Ku, DD; Sun, X1

Other Studies

2 other study(ies) available for monocrotaline and Coronary Disease

ArticleYear
MONOCROTALINE-INDUCED ATHEROMATOUS LESIONS: CORONARY ARTERY OF THE RAT.
    Archives of pathology, 1965, Volume: 79

    Topics: Alkaloids; Coronary Disease; Coronary Vessels; Histocytochemistry; Lipids; Monocrotaline; Pathology; Plaque, Atherosclerotic; Rats; Research; Toxicology

1965
Rosuvastatin provides pleiotropic protection against pulmonary hypertension, right ventricular hypertrophy, and coronary endothelial dysfunction in rats.
    American journal of physiology. Heart and circulatory physiology, 2008, Volume: 294, Issue:2

    Topics: Animals; Blood Pressure; Blotting, Western; Body Weight; Coronary Disease; Endothelium, Vascular; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Monocrotaline; Nitric Oxide; Organ Size; Poisons; Pyrimidines; Rats; Rats, Sprague-Dawley; Rosuvastatin Calcium; Sulfonamides

2008